AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO) committed to delivering excellence in the biopharmaceutical industry. By providing end-to-end development and manufacturing services for proteins, pDNA, mRNA, viral vectors, and genetically engineered cells, the company plays a vital role in accelerating the path from clinical trials to commercialization for its clients.
With a robust network of cGMP-compliant facilities spanning the U.S., Europe, and Asia, AGC Biologics empowers over 2,500 dedicated professionals to solve complex manufacturing challenges. Their culture is firmly rooted in the core values of Knowledge, Trust, Quality, Ingenuity, Accountability, and Teamwork, ensuring that every therapy produced has a meaningful impact on patient lives worldwide.